How have UDG shares performed in 2024?

UDG Healthcare's stock was trading at GBX 1,079 at the beginning of the year. Since then, UDG stock has increased by 0.0% and is now trading at GBX 1,079. View the best growth stocks for 2024 here .

Is UDG Healthcare a good dividend stock?

UDG Healthcare (LON:UDG) pays an annual dividend of GBX 0.17 per share and currently has a dividend yield of 1.17%. The dividend payout ratio is 0.67%. This payout ratio is at a healthy, sustainable level, below 75%. Read our dividend analysis for UDG .

What other stocks do shareholders of UDG Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other UDG Healthcare investors own include Carillion (CLLN) , NBT Bancorp (NBTB) , CRH (CRH) , Standard Life Aberdeen (SL) , BT Group - CLASS A (BT.A) , Carclo (CAR) , CBS (CBS) , Greencore Group (GNC) , Allergan (AGN) and Aviva (AV) .

How do I buy shares of UDG Healthcare?

Shares of UDG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

LON:UDG

UDG Healthcare (UDG) Share Price, News & Analysis

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)

Free UDG Stock Alerts

GBX 1,079

0.00 (0.00%)

(As of 08/16/2021)

Compare

Today's Range: 1,079
▼
1,079
50-Day Range: 1,079
▼
1,079
52-Week Range: 688.50
▼
1,099

Volume: N/A
Average Volume: 1.39 million shs
Market Capitalization: £2.72 billion

P/E Ratio: 42.48
Dividend Yield: 0.02%
Price Target: N/A

Stock Analysis

Get UDG Healthcare alerts:

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About UDG Healthcare Stock (LON:UDG)

UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates in two segments, Ashfield and Sharp. The Ashfield segment offers commercialization services for the pharmaceutical and healthcare industry in the areas of advisory, communications, and commercial and clinical services. This segment supports healthcare professionals and patients at various stages of the product life cycle; and provides field and contact center sales teams, healthcare communications, patient support, audit, advisory, medical information, and event management services to approximately 300 healthcare companies. The Sharp segment provides contract and clinical trial packaging services for the pharmaceutical and biotechnology industries; serialization solutions; and clinical IRT services. The company was formerly known as United Drug plc and changed its name to UDG Healthcare plc in August 2013. UDG Healthcare plc was founded in 1948 and is heaquartered in Dublin, the Republic of Ireland.

UDG Stock Price History

30 days | 90 days | 365 days | Advanced Chart

UDG Stock News Headlines

February 23, 2024 | msn.com

More than 50 people sent to hospitals after odor sickens some at Lehigh Valley pharmaceutical company [Updated]

February 15, 2024 | thestreet.com

UDG Healthcare Plc ADR

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

December 12, 2023 | finance.yahoo.com

CD&R Announces New Partners

November 27, 2023 | finance.yahoo.com

Care Communications Market - Personal Care Segment Witnessed Growth At A Rapid Rate | Explained In Detail

October 26, 2023 | finance.yahoo.com

Clinical Trials Supplies Market Worth $3.29 Billion by 2027 - Exclusive Report by The Insight Partners

October 3, 2023 | finance.yahoo.com

Clinical Trial Supplies Market Size Will Reach USD 4.9 Bn by 2032

October 2, 2023 | lse.co.uk

Advanced Medical Solutions appoints non-executive director as chair

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

September 26, 2023 | benzinga.com

Medical Packaging Market Poised for Growth, Expected to Reach US$113.68 Billion by 2025

September 7, 2023 | msn.com

Mark Kleinman: Natwest chair’s in-tray, Skarbek’s return and the Tata Steel saga

August 10, 2023 | msn.com

‘Rani' Alia Bhatt's sarees can now be yours, for real! Here's how

May 25, 2023 | uk.finance.yahoo.com

Global Healthcare Contract Sales Organizations Market to 2030: Adoption of Digital Technologies Drives Growth

May 16, 2023 | marketwatch.com

Clinical Trial Supplies Market Research | 2023-2030

May 8, 2023 | marketwatch.com

2023 Clinical Trial Supplies Market: Trends and Forecast 2031 | A Detailed Sales Channel Analysis Report

May 3, 2023 | marketwatch.com

Monodose Packs Market Key Players and Competitive Landscape till 2031

April 28, 2023 | marketwatch.com

Clinical Trial Supplies Market Overview and Scope By 2031

April 27, 2023 | marketwatch.com

Monodose Packs Market Complete Overview till 2031

April 24, 2023 | forbes.com

Iasis Healthcare

April 15, 2023 | thetimes.co.uk

FTSE 250 at risk as private equity prepares to take more British companies off the table

April 7, 2023 | marketwatch.com

Pharmaceutical Unit Dose Packaging Market | Regional Forecast to 2030

March 28, 2023 | marketwatch.com

Clinical Trial Supply and Logistic for Pharmaceutical Market Growth and Forecast till 2031

March 21, 2023 | marketwatch.com

Global Clinical Trial Supplies Market Size by Type (, Logistics & Distribution, Supply Chain Management, Other,) Forecast from 2023 to 2028

February 14, 2023 | marketwatch.com

Clinical Trial Supply and Logistic for Pharmaceutical Market Outlook 2023 and Forecast to 2029 with Top Countries Data

February 13, 2023 | marketwatch.com

Clinical Trial Supplies Market Detailed Analysis, Business Overview, Upcoming Trends and Growth Opportunities Which Will Beneficial for Future

February 8, 2023 | marketwatch.com

Stick Packaging Market Growth and Status Explored in a New Research Report 2029

February 6, 2023 | marketwatch.com

Stick Packaging Market Size 2023 | Key Growth Drivers, Latest Opportunities, Increasing Demand, Top Players and Regional Forecast to 2028

See More Headlines

Receive UDG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for UDG Healthcare and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: LON
Sector: Medical
Industry: Medical Distribution
Sub-Industry: N/A
Current Symbol: LON:UDG
CUSIP: N/A
CIK: N/A
Web: www.udghealthcare.com
Phone: +353-1-4689000
Fax: N/A
Employees: 9,000
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: 42.48
Forward P/E Ratio: 20.75
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 36.63
Current Ratio: 1.91
Quick Ratio: 1.80

Sales & Book Value

Annual Sales: £1.25 billion
Price / Sales: 2.18
Cash Flow: GBX 91.60 per share
Price / Cash Flow: 11.78
Book Value: GBX 411.10 per share
Price / Book: 2.62

Miscellaneous

Outstanding Shares: 251,883,000
Free Float: N/A
Market Cap: £2.72 billion
Optionable: Not Optionable
Beta: N/A

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

Mr. Brendan Patrick McAtamney (Age 58)
CEO & Exec. Director
Comp: $1.49M
Mr. Nigel Clerkin (Age 47)
CFO & Exec. Director
Comp: $1.04M
Mr. Ryan Quigley
Chief Operating Officer
Keith Byrne
Head of Investor Relations, Strategy & Corp. Communications
Eleanor Garvey
Group Head of Quality & Compliance
Mr. Damien Moynagh
Gen. Counsel & Company Sec.
Mr. Liam Logue
Exec. VP of Corp. Devel.
Ms. Lucy MacLauchlan-Wharton
Global Head of Marketing and Communications
Ms. Eimear Kenny (Age 51)
Exec. VP of HR
Mr. Tom Mitchell
Uk Head of Syndicated Services for Ashfield

Key Competitors

View All Competitors

UDG Stock Analysis - Frequently Asked Questions

How have UDG shares performed in 2024?: UDG Healthcare's stock was trading at GBX 1,079 at the beginning of the year. Since then, UDG stock has increased by 0.0% and is now trading at GBX 1,079.
View the best growth stocks for 2024 here.
Is UDG Healthcare a good dividend stock?: UDG Healthcare (LON:UDG) pays an annual dividend of GBX 0.17 per share and currently has a dividend yield of 1.17%. The dividend payout ratio is 0.67%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for UDG.
What other stocks do shareholders of UDG Healthcare own?: Based on aggregate information from My MarketBeat watchlists, some companies that other UDG Healthcare investors own include Carillion (CLLN), NBT Bancorp (NBTB), CRH (CRH), Standard Life Aberdeen (SL), BT Group - CLASS A (BT.A), Carclo (CAR), CBS (CBS), Greencore Group (GNC), Allergan (AGN) and Aviva (AV).
How do I buy shares of UDG Healthcare?: Shares of UDG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:UDG) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial